# A Comparison of Once a Day Dose Compared to 2 Doses/Day

> **NCT00505778** · PHASE3 · COMPLETED · sponsor: **Warner Chilcott** · enrollment: 1027 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** Mesalamine Once-Daily
- **DRUG:** Mesalamine Twice-Daily

## Key facts

- **NCT ID:** NCT00505778
- **Lead sponsor:** Warner Chilcott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 1027 (ACTUAL)
- **Last updated:** 2013-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00505778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00505778, "A Comparison of Once a Day Dose Compared to 2 Doses/Day". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00505778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*